Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NTP-TELMISARTAN HCTZ DIN 02388758

Status: Cancelled Pre Market
Holder: TEVA CANADA LIMITED
Molecule: TELMISARTAN (TELMISARTAN SODIUM)

Health Canada record

Active ingredient(s)TELMISARTAN (TELMISARTAN SODIUM) 80.0 MG; HYDROCHLOROTHIAZIDE 12.5 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC09DA07 TELMISARTAN AND DIURETICS
Original market date
Current status date13-Jun-2017
SourceHealth Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TELMISARTAN (TELMISARTAN SODIUM)

DINProductCompanyFormStrengthStatus
02330288TEVA-TELMISARTAN HCTZTEVA CANADA LIMITEDTabletTELMISARTAN (TELMISARTAN SODIUM) 80 MG; HYDROCHLOROTHIAZIDE 12.5 MGMarketed
02379252TEVA-TELMISARTAN HCTZTEVA CANADA LIMITEDTabletTELMISARTAN (TELMISARTAN SODIUM) 80.0 MG; HYDROCHLOROTHIAZIDE 25.0 MGMarketed
02388782NTP-TELMISARTAN HCTZTEVA CANADA LIMITEDTabletTELMISARTAN (TELMISARTAN SODIUM) 80.0 MG; HYDROCHLOROTHIAZIDE 25.0 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
147812013-10-04Abbreviated New Drug Submission (ANDS)MERGER/BUYOUT
134782012-07-12Abbreviated New Drug Submission (ANDS)New manufacturer and product name
Request a quote for NTP-TELMISARTAN HCTZ

How to read a Canadian DIN record